Healthcare / Medical - PharmaceuticalsUpdated 2026-05-10 22:07 UTC

LON/0QND stock hub

LON/0QND has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/0QNDis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

5.7B

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/0QND

In the news

Latest news · LON/0QND

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E32.3

P25 12.9P50 16.9P75 23.5

Trailing P/E40.8

P25 15.9P50 22.9P75 35.8

ROE10.4

P25 -54.2P50 2.1P75 13.7

ROIC10.7

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/0QND market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

230

Groups with data

Currency

CHF

Showing 230 of 230 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Switzerland
Country code	UK
Employees	2,363
Employees Change	388%
Employees Change Percent	17.58
Enterprise value	CHF 5.7B
Exchange	London Stock Exchange
Financial currency	CHF
First seen	2026-05-10
Industry	Medical - Pharmaceuticals
Isin	CH1176493729
Last refreshed	2026-05-10
Market cap	CHF 5.7B
Price	CHF 81.55
Price currency	CHF
Rev Per Employee	275,618.16x
Sector	Healthcare
Sic	2833
Symbol	lon/0QND
Website	https://www.bachem.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.45%
EV Earnings	40.96x
EV/EBIT	36.16x
EV/EBITDA	28.71x
EV/FCF	-126.99x
EV/Sales	8.7x
FCF yield	-0.79%
Forward P/E	32.34x
P/B ratio	4.16x
P/E ratio	40.76x
P/S ratio	8.73x
PE Ratio10 Y	54.6x
PE Ratio3 Y	34.31x
PE Ratio5 Y	40.98x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	24.07%
EBITDA Margin	30.32%
Gross margin	28.74%
Gross Profit	CHF 187.2M
Gross Profit Growth	-5.65%
Gross Profit Growth Q	-9.83%
Gross Profit Growth3 Y	3.65%
Gross Profit Growth5 Y	4.66%
Net Income	CHF 139.4M
Net Income Growth	23.74%
Net Income Growth Q	17.36%
Net Income Growth Quarters	5%
Net Income Growth Years	3%
Net Income Growth3 Y	9.42%
Net Income Growth5 Y	8.6%
Pretax Margin	22.5%
Profit Margin	21.41%
Profit Per Employee	CHF 59,001
Profitable Years	14
ROA	5.19
Roa5y	5.8
ROCE	9.82
ROE	10.44
Roe5y	10.29
ROIC	10.7
Roic5y	13.18

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	22.22%
Cagr1y	68.68%
Cagr3y	-5.97%
Cagr5y	-0.9%
Div CAGR3	7.79%
Div CAGR5	10.47%
EPS Growth	23.77
EPS Growth Q	16.56
EPS Growth Quarters	5
EPS Growth Years	3
EPS Growth3 Y	9.4
EPS Growth5 Y	8.48
OCF Growth	85.6%
OCF Growth Q	220.31%
OCF Growth10 Y	8.97%
OCF Growth3 Y	3.7%
OCF Growth5 Y	14.72%
Revenue Growth	14.84x
Revenue Growth Q	4.7x
Revenue Growth Quarters	7x
Revenue Growth Years	13x
Revenue Growth3 Y	6.36x
Revenue Growth5 Y	5.31x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CHF 0.34
Assets	CHF 2B
Cash	CHF 29M
Current Assets	CHF 686.1M
Current Liabilities	CHF 382.8M
Debt	CHF 56.5M
Debt EBITDA	CHF 0.29
Debt Equity	CHF 0.04
Debt FCF	CHF -1.26
Equity	CHF 1.4B
Interest Coverage	420.4
Liabilities	CHF 609.4M
Long Term Assets	CHF 1.3B
Long Term Liabilities	CHF 226.7M
Net Cash	CHF -27.4M
Net Cash By Market Cap	CHF -0.48
Net Debt EBITDA	CHF 0.14
Net Debt Equity	CHF 0.02
Tangible Book Value	CHF 1.3B
Tangible Book Value Per Share	CHF 17.89
WACC	8.48

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.79
Inventory Turnover	1.05
Net Working Capital	CHF 328.4M
Quick ratio	0.54
Working Capital	CHF 301.1M
Working Capital Turnover	CHF 1.51

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.03%
Dividend Growth	9.06%
Dividend Growth Years	10%
Dividend per share	CHF 0.85
Dividend Years	11
Dividend Yield	1.15%
Ex Div Date	2026-05-04
Last Dividend	CHF 0.85
Payout Frequency	Annual
Payout Ratio	20.65%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	643.33%
1Y total return	68.62%
200-day SMA	61.92
3Y total return	-16.86%
50-day SMA	65.03
50-day SMA vs 200-day SMA	50over200
5Y total return	-4.4%
All Time High	170.4
All Time High Change	-52.15%
All Time High Date	2021-10-18
All Time Low	10.45
All Time Low Change	680.36%
All Time Low Date	2015-12-03
ATR	3.12
Beta	0.78
Ch YTD	36.14
High	83.1
High52	83.25
High52 Date	2026-05-07
High52ch	-2.04%
Low	80.35
Low52	48.32
Low52 Date	2025-05-23
Low52ch	68.77%
Ma50ch	25.4%
Price vs 200-day SMA	31.69%
RSI	73.63
RSI Monthly	59.17
RSI Weekly	69.04
Sharpe ratio	1.13x
Sortino ratio	2.32
Total Return	1.18%
Tr YTD	37.91
Tr1m	28.84%
Tr1w	10.28%
Tr3m	24.5%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CHF 156.8M
Operating Income Growth	1.65
Operating Income Growth Q	2.78
Operating Income Growth3 Y	8.79
Operating Income Growth5 Y	8.65
Operating margin	24.07

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	74,738,741%
Net Borrowing	22,738,362.8
Shares Insiders	0.26%
Shares Institutions	15.83%
Shares Qo Q	0.49%
Shares Yo Y	-0.03%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CHF -48.1M
Average Volume	32,432.1x
Bv Per Share	18.24
CAPEX	CHF -299.4M
Ch10y	544.6
Ch1m	27.18
Ch1w	10.28
Ch1y	66.45
Ch3m	22.9
Ch3y	-20.09
Ch5y	-9.59
Ch6m	59.98
Change	-1.34%
Change From Open	0.86
Close	82.66
Days Gap	-2.19
Depreciation Amortization	41,023,461.9
Dollar Volume	1,364,861.2
Earnings Date	2026-07-30
EBIT	CHF 156.8M
EBITDA	CHF 197.5M
EPS	CHF 1.86
F Score	4
FCF	CHF -45M
FCF EV Yield	-0.79x
Financing CF	-9,290,428
Fiscal Year End	December
Founded	1,971
Graham Number	29.7085
Graham Upside	-63.57
Income Tax	CHF 7.1M
Investing CF	-304,561,130
Is Primary Listing	0
Last Earnings Date	2026-03-12
Last Report Date	2025-12-31
Last Split Date	2022-05-05
Last Split Type	Forward
Lynch Fair Value	CHF 17.2
Lynch Upside	-78.91
Ma150	60.88
Ma150ch	33.94%
Ma20	71.57
Ma20ch	13.94%
Net CF	-60,164,307
Next Earnings Date	2026-07-30
Open	80.85
P OCF Ratio	22.33
Payment Date	2026-05-06
Position In Range	43.55
Ppne	1,259,421,130.1
Price Date	2026-05-08
Price EBITDA	CHF 28.78
Ptbv Ratio	4.24
Relative Volume	0.51x
Revenue	651,285,718x
SBC By Revenue	0.49x
Share Based Comp	3,162,400
Tax By Revenue	1.09x
Tax Rate	4.86%
Tr6m	62.06%
Volume	16,737
Z Score	5.3

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

LON/0QND dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+1.2%

$0.85 annual per share

Payout ratio

+20.7%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+10.5%

10 consecutive years of growth

Total shareholder yield

+1.2%

Next ex-dividend date: 2026-05-04

Performance

LON/0QND stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/0QND?

Insider, institutional, and short-interest positioning.

Institutional ownership

+15.8%

Share of float held by funds and institutions

Insider ownership

+0.3%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.0%

Negative means the company is buying back shares.

Technical

LON/0QND momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

73.6

Above 70: short-term overbought

Price vs 200-day MA

+31.7%

50/200-day relationship not available

Beta (5Y)

0.78

Less volatile than the market

Sharpe ratio

1.13

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/0QND

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0QND stock rating?

lon/0QND is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0QND analysis?

The full report lives at /stocks/lon/0QND/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0QND?

The latest report frames lon/0QND around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0QND page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.